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Intrauterine growth restriction (IUGR) increases the risk of chronic lung disease 
(CLD), and males have worse outcomes. Altered ratios of omega-6 and omega-3 essential 
fatty acids (EFA) in preterm infants are associated with increased risk of CLD. 
Conversion of omega-6 and omega-3 EFAs require the same set of EFA conversion 
enzymes. We hypothesized that IUGR would alter EFA ratios and EFA conversion 
enzymes in a sex-specific manner in fetal serum, liver and lung. Because maternal 
docosahexanoic acid (DHA) supplementation has been shown to ameliorate lung 
dysfunction in IUGR rats, we further hypothesized that alterations in EFA ratios and EFA 
conversion enzymes would be ameliorated with maternal DHA supplementation. We 
found that IUGR altered EFA ratios and EFA conversion enzymes in a sex-specific 
manner. IUGR induced changes in male circulating EFAs that correlate with EFA ratios 
seen in male preterm infants at increased risk for CLD. Maternal DHA supplementation 
ameliorated the altered circulating EFAs in male IUGR rats. IUGR induced changes in 
liver and lung EFA conversion enzyme mRNA and protein did not explain alterations in 
circulating and lung EFA ratios. We conclude that IUGR induces sex-specific changes in 
circulating EFA ratios and liver EFA conversion enzymes in newborn IUGR rat pups. We 
speculate that IUGR induced changes in EFA levels may occur as a result of alterations 
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Intrauterine Growth Restriction 
Intrauterine growth restriction (IUGR) occurs when a fetus is prevented from 
reaching its full growth potential in utero. IUGR is defined as a birth weight that falls 
below the 10th percentile for gestational age [1, 2], and affects up to 10% of pregnancies 
annually in the United States. The most common cause of IUGR in developed countries 
is preeclampsia, which limits oxygen and nutrient delivery to the developing fetus by 
restricting uteroplacental blood flow [1, 3]. This restriction in oxygen and nutrient 
delivery has many consequences on the developing fetus including increased perinatal 
morbidity and mortality [4], with male infants having worse outcomes than female 
infants . Specifically, IUGR infants, especially those born prematurely, have an increased 
risk of developing chronic lung disease (CLD) [5, 6]. In addition, male IUGR infants 
have worse respiratory outcomes and higher rates of CLD compared to female IUGR 
infants [7]. A mechanism that may contribute to lung disease seen in IUGR infants 
involves circulating essential fatty acids (EFA).  
 
Serum Essential Fatty Acid Levels and CLD in Premature Infants 
Essential fatty acids (EFA) are modulators of inflammation, and play key roles in 
membrane fluidity, cell signaling and gene transcription [8]. The omega-6 and omega-3 
fatty acids are essential. In the omega-6 pathway, linoleic acid (LA) is ultimately 
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converted to arachadonic acid (AA). In the omega-3 pathway, linolenic acid (ALA) is 
converted to eicosapentaenoic acid (EPA) and docosahexanoic acid (DHA). In general, 
the omega-6 fatty acids are pro-inflammatory, while the omega-3 fatty acids are anti-
inflammatory. Alterations in the relative amounts of omega-6 to omega-3 fatty acids have 
been associated with neonatal morbidities [9].  
A recent study showed that altered serum EFA levels in premature infants are 
associated with increased risk of developing CLD [9]. CLD have increased levels of total 
omega-6 relative to omega-3 EFA’s [9]. Furthermore, the ratios of EFA within the 
omega-6 and omega-3 pathway appear to be more important than the overall amounts. An 
increased ratio of AA to DHA and decreased ratio of DHA to ALA is associated with 
CLD in premature infants [9]. An increased ratio of AA to LA represents an increase in 
the conversion along the omega-6 pathway [9]. Similarly, a decreased ratio of DHA to 
ALA represents a decrease in conversion along the omega-3 pathway [9]. Changes in 
EFA ratios in newborn infants may result from either altered placental transport of EFA, 
or from changes in the local conversion of EFA along the omega-6 or omega-3 pathways.  
 
Essential Fatty Acid Metabolism 
Conversion of fatty acids along the omega-6 and omega-3 pathways utilizes the 
same groups of elongase and desaturase enzymes (Figure 1). Δ5-desaturase and Δ6-
desaturase introduce double bonds into the growing fatty acid chain, and elongase 2 and 
elongase 5 are responsible for the addition of 2 carbon molecules to the fatty acid chain. 
Levels of Δ5-desaturase, Δ6-desaturase, elongase 2 and elongase 5 affect the relative 
concentrations of the EFAs along the omega-6 and omega-3 pathway.
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Changes in liver activity of Δ5-desaturase, Δ6-desaturase, elongase 2 and 
elongase 5 may account for altered serum EFA levels in IUGR infants. In the fetus, EFAs 
are processed in the liver before being transported in the serum to various tissues where 
Δ5-desaturase, Δ6-desaturase, elongase 2 and elongase 5 can act at the local level to 
further alter EFA profiles.  
 
IUGR in the Rat Model 
Our lab previously showed that surgically induced IUGR in the rat predisposes 
the rat to lung dysfunction, and male IUGR rats have worse outcomes than female IUGR 
rats [10].  We have shown that rats born with IUGR have delayed alveolar formation, 
stemming from reduced elastin fiber deposition and improper thinning of lung 
mesenchyme at birth [10, 11].  IUGR alters surfactant in rat lung [11], and rats born with 
IUGR have increased lung compliance [10]. Interestingly, the molecular, structural and 
functional lung changes observed in our IUGR rat model are ameliorated with maternal 
supplementation of the EFA DHA [12].  
How EFA and Δ5-desaturase, Δ6-desaturase, elongase 2 and elongase 5 levels are 
affected by IUGR, and how maternal DHA supplementation impacts EFA and Δ5-
desaturase, Δ6-desaturase, elongase 2 and elongase 5 levels in IUGR offspring is 
unknown. We hypothesize that IUGR will alter EFA ratios as well as Δ5-desaturase, Δ6-
desaturase, elongase 2 and elongase 5 levels in a sex-specific manner in fetal serum, liver 
and lung. We further hypothesize that alterations in EFA ratios and Δ5-desaturase, Δ6-
















Figure 1: Pathways of omega-6 and omega-3 metabolism. LA, linoleic 
acid; AA, arachidonic acid; ALA, α-linolenic acid; EPA, eicosapentaenoic 
acid; DHA, docosahexaenoic acid. Both the omega-3 and omega-6 











This project utilized a rat model of IUGR induced by uteroplacental insufficiency 
(UPI). Pregnant dams were assigned to standard rat chow, or to rat chow with DHA, and 
to either the control group or the IUGR group. To induce IUGR, pregnant rats were 
anesthetized with ketamine and zylazine and the inferior uterine arteries were ligated at 
day 19 of gestation. Rats in the control group were subjected to identical anesthesia 
procedures. At term gestation (day 21.5) fetal rat pups were delivered via caesarean 
section. Rat pups were killed by decapitation, and blood, lung and liver tissues were 
harvested and flash frozen in liquid nitrogen. Tissues were stored at -80C until use. 
 
Maternal DHA Supplementation 
DHA was provided via a custom diet containing either 0.1% DHA or 1% DHA. 
Diets were constructed by replacing 0.1% or 1% of the soybean oil in standard rat chow 
with purified DHA.  The 0.1% and 1% DHA diets maintained the macronutrient content 
of the standard rat chow diet (21.8% protein, 40.8% carbohydrate and 5.4% fat with a 
caloric density of 3 Kcal/g). One percent DHA diet was used for serum and lung EFA. 
All other experiments used 0.1% DHA diet. Pregnant rats were fed regular diet, 0.1% 





Six sex-matched nonsibling rat pups were assigned to each study group. The 
study groups were control, IUGR, DHA-control, and DHA-IUGR. A sample size of 6 in 
each group was used, because we have shown that this size sample is sufficient to show a 
statistically significant difference with a 10% change. 
 
Serum and Lung EFA Analysis 
 Prior to the start of this study, serum and lung EFA levels of fetal rat pups from 
dams fed either a standard rat chow diet or a rat chow diet with 1% DHA were analyzed 
via gas chromatography by a collaborator. The lung and serum EFA raw data were 
analyzed for this study.  
Conversion along the omega-6 and omega-3 pathway was determined by 
calculating the ratio of AA to LA and the ratio of DHA to ALA, respectively. The ratios 
of the total omega-6 and omega-3, as well as end point fatty acids AA and DHA, were 
also calculated.  
 
Real-Time Reverse Transcriptase PCR 
Real-time reverse transcriptase PCR was used to quantify mRNA levels of Δ5 
desaturase, Δ6 desaturase, elongase 2 and elongase 5 within lung and liver samples. The 
genes that code for the EFA conversion enzymes are as follows: FADS1 codes for Δ5-
desaturase, FADS2 codes for Δ6-desaturase, ELOVL2 codes for elongase 2, and 
ELOVL5 codes for elongase 5. Total mRNA was extracted from lung and liver using a 
“NucleoSpin RNA II” RNA extraction kit according to manufacturer protocol. Total
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RNA was quantified and 1 µg was used to synthesize cDNA with the “High Capacity 
cDNA Reverse Transcription Kit” (Applied Biosystems). The following assay-on-
demand primer/probe sets were used: FADS1-Rn00584915_m1, FADS2-
Rn00580220_m1, ELOVL2-Rn01450663_m1, ELOVL5-Rn00592812_m1. GAPDH 
primer and probe sequences; Forward: CAAGATGGTGAAGGTCGGTGT; Reverse: 
CAAGAGAAGGCAGCCCTGGT; Probe: GCGTCCGATACGGCCAAATCCG.  
 
Western Blotting 
Western blotting was used to determine relative abundance of lung and liver Δ5 
desaturase, Δ6 desaturase, elongase 2 and elongase 5 protein. Lung and liver proteins 
were isolated by homogenizing in RIPA buffer with a protease inhibitor, followed by 
centrifuging at 10,000 rpm at 4oC for 10 minutes. Proteins were quantified using the 
Bicinchoninic Acid Protein Assay Kit (Pierce). Immunoblotting was performed using 
standard procedures. The following primary antibodies were used: Anti-FADS1 antibody 
[EPR6898] (abcam); Anti-FADS2 (H-40): sc-98480 (Santa Cruz Biotechnology); Anti-
ELOVL2 (S-16): sc-54874 (Santa Cruz Biotechnology, Inc.); and Anti-ELOVL5 (G-18): 
sc-54882 (Santa Cruz Biotechnology). Following incubation with the appropriate 
secondary antibodies, enhanced chemiluminesence was used to determine signaling.  
 
Statistical Analysis 
Statistical analysis was performed using a Mann-Whitney U test in Statview 
software. Two way ANOVA was performed to determine the independent effect of 










Effect of IUGR on Circulating EFAs 
 
For each result the effect of IUGR alone (IUGR), DHA alone (DHA-control) and 
the combination of DHA and IUGR (DHA-IUGR) will be presented. In male serum, 
IUGR increased the ratio of total omega-6 to total omega-3 (p=0.0062) compared to 
control. In contrast, DHA-control decreased the ratio of total omega-6 to total omega-3 
(p=0.0039) compared to control. DHA-IUGR decreased the ratio of total omega-6 to total 
omega-3 (p=0.0039) compared to control, and increased the ratio of total omega-6 to total 
omega-3 (p=0.0374) compared to DHA-control (Figure 2A). A significant IUGR-DHA 
interaction (p=0.0001) was observed in male serum.  
In female serum, IUGR did not significantly alter the ratio of total omega-6 to 
total omega-3  (p=0.157) compared to control. DHA-control decreased the ratio of total 
omega-6 to total omega-3 (p=0.0105) compared to control. DHA-IUGR decreased the 
ratio of total omega-6 to total omega-3 (p=0.0209) compared to control, and increased the 
ratio of total omega-6 to total omega-3 (p=0.0105) compared to DHA-control (Figure 
2B). A significant DHA-sex interaction (p=0.0001) and a significant IUGR-sex 
interaction (p=0.0008) was observed 
In male serum, IUGR increased the ratio of AA to LA (p=0.0062) compared to 
control. Similarly, DHA-control increased the ratio of AA to LA (p=0.0039) compared to 
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control. DHA-IUGR increased the ratio of AA to LA (p=0.0062) compared to control 
(Figure 3A).  A significant DHA-IUGR interaction (p=0.0001) was observed.  
In female serum, IUGR increased the ratio of AA to LA (p=0.05) compared to 
control. DHA-control increased the ratio of AA to LA (p=0.009) compared to control. 
DHA-IUGR increased the ratio of AA to LA (p=0.0143) compared to control (Figure 
3B). A significant DHA-sex interaction (p=0.0002) and a significant IUGR-sex 
interaction (p=0.0022) was observed. 
In male serum, IUGR decreased the ratio of DHA to ALA (p=0.0065) compared 
to control. In contrast, DHA-control increased the ratio of DHA to ALA (p=0.0039) 
compared to control. DHA-IUGR decreased the ratio of DHA to ALA (p=0.0039) 
compared to DHA-IUGR (Figure 4A). In male serum, a significant DHA-IUGR 
interaction (p=0.0002) was observed.  
In female serum, IUGR did not alter the ratio of DHA to ALA (p=0.83) compared 
to control. DHA-control increased the ratio of DHA to ALA (p=0.0039) compared to 
control. Similarly, DHA-IUGR increased the ratio of DHA to ALA (p=0.0062) compared 
to control (Figure 4B). Additionally, a significant DHA-sex interaction (p=.0096) was 
observed. 
In male serum, IUGR increased the ratio of AA to DHA (p=0.0062) compared to 
control. DHA-control decreased the ratio of AA to DHA (p=0.0039) compared to control. 
DHA-IUGR decreased the ratio of AA to DHA (p=0.0039) compared to control, and 
increased the ratio of AA to DHA (p=0.0039) compared to DHA-control (Figure 5A). In 




In female serum, IUGR with regular diet did not alter the ratio of AA to DHA 
(p=0.85) compared to control. DHA-control decreased the ratio of AA to DHA 
(p=0.0039) compared to control. Similarly, DHA-IUGR decreased the ratio of AA to 
DHA (p=0.0062) compared to control, and increased the ratio of AA to DHA (p=0.0176) 
compared to DHA-control (Figure 5B). In female serum, a significant DHA-IUGR 
interaction (p=0.0305) was observed. Additionally, a significant DHA-sex interaction 
(p=0.0029) was observed. 
 
Effect of IUGR on Liver EFA Conversion Enzymes 
In male liver, IUGR decreased Δ5 desaturase mRNA (p=0.0374) compared to 
control. Similarly, DHA-IUGR decreased Δ5 desaturase mRNA (p=0.0104) compared to 
control (Figure 6A).  
In female liver, IUGR, DHA-control, and DHA-IUGR did not alter Δ5 desaturase 
mRNA compared to control (Figure 6B). In female liver, a significant IUGR-DHA 
interaction (p=0.017) was observed. Additionally, a significant IUGR-sex interaction 
(p=0.0339) was observed. 
In male liver, IUGR decreased Δ5 desaturase protein (p=0.0105) compared to 
control. Similarly, DHA-control decreased Δ5 desaturase protein (p=0.0209) compared to 
control (Figure 7A).  In male liver, a significant DHA-IUGR interaction (p=0.0066) was 
observed. In female liver, IUGR, DHA-con and DHA-IUGR did not significantly alter Δ5 
desaturase protein compared to control (Figure 7B). 
In male liver, IUGR decreased Δ6 desaturase mRNA (p=0.025) compared to 
control. DHA-control decreased Δ6 desaturase mRNA (p=0.0039) compared to control. 
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DHA-IUGR decreased Δ6 desaturase mRNA (p=0.0039) compared to control, and 
decreased Δ6 desaturase mRNA (p=0.0374) compared to DHA-control (Figure 8A).  
In female liver, IUGR did not alter Δ6 desaturase mRNA (p=0.5218) compared to 
control. In contrast, DHA-IUGR decreased Δ6 desaturase mRNA (p=0.0106) compared 
to control (Figure 8B). 
In male liver, IUGR did not alter Δ6 desaturase protein (p=0.17) compared to 
control. DHA-control increased Δ6 desaturase protein (p=0.0106) compared to control. In 
contrast, DHA-IUGR decreased Δ6 desaturase protein (p=0.0176) compared to DHA-
control (Figure 9).  
In female liver, IUGR did not alter Δ6 desaturase protein (p=0.5218) compared to 
control. In contrast, DHA-control increased Δ6 desaturase protein (p=0.0039) compared 
to control. DHA-IUGR decreased Δ6 protein (p=0.0062) compared to control (Figure 
9B). Additionally, in female liver a significant IUGR-DHA interaction (p=0.0353) was 
observed.  
In male liver, IUGR did not alter elongase 2 mRNA (p=0.3785) compared to 
control. DHA-control decreased elongase 2 mRNA (p=0.0374) compared to control. 
Similarly, DHA-IUGR decreased elongase 2 mRNA (p=0.0039) compared to control 
(Figure 10A).  
In female liver, IUGR did not alter elongase 2 mRNA (p=0.465) compared to 
control. DHA-control decreased elongase 2 mRNA (p=0.0065) compared to control. 
DHA-IUGR decreased elongase 2 mRNA (p=0.0062) compared to control (Figure 10B). 
Elongase 2 protein could not be measured because the antibody did not work, 
potentially because liver elongase 2 expression is too low to measure in the newborn rat.
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In male liver, IUGR did not alter elongase 5 mRNA (p=0.0656) compared to 
control. DHA-control decreased elongase 5 mRNA (p=0.0039) compared to control. 
DHA-IUGR decreased elongase 5 mRNA (p=0.0039) compared to control (Figure 11A).  
In female liver, IUGR did not alter elongase 5 mRNA (p=0.298) compared to 
control. DHA-control decreased elongase 5 mRNA (p=0.0453) compared to control. 
DHA-IUGR did not alter elongase 5 mRNA (p=0.078) (Figure 11B). Additionally, a 
significant IUGR-sex interaction (p=0.0341) was observed. Elongase 5 protein could not 
be measured because the antibody did not work, potentially because liver elongase 5 
expression is too low in the newborn rat.  
 
Effect of IUGR on Lung EFA Levels 
DHA-control and DHA-IUGR EFA levels in the lung were not measured for this 
study. In male lung, IUGR did not alter the ratio of total omega-6 to total omega-3 
(p=0.1495) compared to control (Figure 12A). In contrast, in female lung IUGR 
increased the ratio of total omega-6 to total omega-3 (p=0.0105) compared to control 
(Figure 12B). Additionally, a significant IUGR-sex interaction (p=0.0459) was observed 
In male lung, IUGR decreased the ratio of AA to LA (p=0.0163) compared to 
control (Figure 13A). In contrast, in female lung IUGR did not alter the ratio of AA to 
LA (p=0.7488) compared to control (Figure 13B).  
In male lung, IUGR did not alter the ratio of DHA to ALA (p=0.873) compared to 
control (Figure 14A). Similarly, in female lung IUGR did not alter the ratio of DHA to 
ALA (p=0.831) compared to control (Figure 14B).
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In male lung, IUGR did not significantly alter the ratio of AA to DHA (p=0.7488) 
compared to control (Figure 15A). Similarly, in female lung IUGR did not significantly 
alter the ratio of AA to DHA (p=0.2012) compared to control (Figure 15B). 
 
Effect of IUGR on Lung EFA Conversion Enzyme Levels 
 In male lung, IUGR, DHA-control, and DHA-IUGR did not alter FADS1 mRNA 
(Figure 16A). Similarly, in female lung IUGR, DHA-control, and DHA-IUGR did not 
alter FADS1 mRNA (Figure 16B). 
In male lung, IUGR did not alter Δ5 desaturase protein compared to control 
(Figure 17A). Male lung DHA-control and DHA-IUGR blots were unsuccessful due to 
the protein being degraded in the available samples.  
In contrast, in female lung IUGR increased Δ5 desaturase protein (p=0.006) 
compared to control, DHA-IUGR increased Δ5 desaturase protein (p=0.0039) compared 
to control, and increased Δ5 desaturase protein (p=0.0039) compared to DHA-control 
(Figure 17B). 
In male lung, IUGR increased Δ6 desaturase mRNA (p=0.0285) compared to 
control. DHA-IUGR decreased Δ6 desaturase mRNA (p=0.0283) compared to control 
(Figure 18A). Additionally, a significant DHA-IUGR interaction (p=0.0221) was 
observed. Male lung DHA-control and DHA-IUGR blots were unsuccessful due to the 
protein being degraded in the available samples. In female lung, IUGR, DHA-control, 
and DHA-IUGR did not alter Δ6 desaturase mRNA (Figure 18B). 
In male lung, IUGR did not alter Δ6 desaturase protein compared to control 
(Figure 19A). In contrast, in female lung IUGR increased Δ6 desaturase protein 
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(p=0.001) compared to control. DHA-IUGR increased Δ6 desaturase protein (p=0.003) 
compared to control, and increased Δ6 desaturase protein (p=0.003) compared to DHA-
control (Figure 19B). 
In male lung, IUGR did not alter elongase 2 mRNA (p=0.0833) compared to 
control. DHA-control decreased elongase 2 mRNA (p=0.05) compared to control. DHA-
IUGR increased elongase 2 mRNA (p=0.0446) compared to DHA-control (Figure 20A).  
In female lung, IUGR did not alter elongase 2 mRNA (p=0.2733) compared to 
control. DHA-control decreased elongase 2 mRNA (p=0.0176) compared to control 
(Figure 20B). 
Elongase 2 protein could not be measured because the antibody did not work, 
potentially because lung elongase 2 expression is too low to measure in the newborn rat.  
In male lung, IUGR did not alter elongase 5 mRNA (p=0.715) compared to 
control. DHA-control increased elongase 5 mRNA (p=0.009) compared to control. DHA-
IUGR increased elongase 5 mRNA (p=.00283) compared to control, and decreased 
elongase 5 mRNA (p=0.0472) compared to DHA-IUGR (Figure 21A).  
In female lung, IUGR did not alter elongase 5 mRNA (p=0.2002) compared to 
control. DHA-control increased elongase 5 mRNA (p=0.2002) compared to control. 
DHA-IUGR increased elongase 5 mRNA (p=0.0106) compared to control (Figure 21B). 
Additionally, a significant DHA-IUGR interaction (p=0.0134) was observed.  
Elongase 5 protein could not be measured because the antibody did not work, 








         
Figure 2. Ratio of total omega-6 to total omega-3 in male and female serum. A) Male 
serum ratio of total omega-6 to total omega-3 EFA. B) Female serum ratio of total 
omega-6 to total omega-3 EFA. * different from regular diet control (Mann-Whitney U). 




           
 
Figure 3. Ratio of AA to LA in male and female serum. A) Male serum ratio of AA to 
LA. B) Female serum ratio of AA to LA. * different from regular diet control (Mann-
Whitney U). ^ different from DHA control (Mann-Whitney U). 
 
A)	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Figure 4. Ratio of DHA to ALA in male and female serum. A) Male serum ratio of DHA 
to ALA. B) Female serum ratio of DHA to ALA. * different from regular diet control 




            
 
Figure 5. Ratio of AA to DHA in male and female serum. A) Male serum ratio of AA to 
DHA. B) Female serum ratio of AA to DHA. * different from regular diet control (Mann-











           
 
Figure 6. Δ5 desaturase mRNA in male and female liver. A) Male liver Δ5 desaturase 
mRNA. B) Female liver Δ5 desaturase mRNA. * different from regular diet control 




          
 
Figure 7. Δ5 desaturase protein in male and female liver. A) Male liver Δ5 desaturase 
protein. B) Female liver Δ5 desaturase protein. * different from regular diet control 










        
 
Figure 8. Δ6 desaturase mRNA in male and female liver. A) Male liver Δ6 desaturase 
mRNA. B) Female liver Δ6 desaturase mRNA. * different from regular diet control 




            
 
Figure 9. Δ6 desaturase protein in male and female liver. A) Male liver Δ6 desaturase 
protein. B) Female liver Δ6 desaturase protein. * different from regular diet control 









         
 
Figure 10. Elongase 2 mRNA in male and female liver. A) Male liver elongase 2 mRNA. 
B) Female liver elongase 2 mRNA. * different from regular diet control (Mann-Whitney 




            
 
Figure 11. Elongase 5 mRNA in male and female liver. A) Male liver elongase 5 mRNA. 
B) Female liver elongase 5 mRNA. * different from regular diet control (Mann-Whitney 












            
 
 
Figure 12. Ratio of total omega-6 to total omega-3 in male and female lung. A) Male lung 
ratio of total omega-6 to total omega-3 EFA. B) Female lung ratio of total omega-6 to 
total omega-3 EFA. * different from regular diet control (Mann-Whitney U). ^ different 




             
 
 
Figure 13. Ratio of AA to LA in male and female lung. A) Male lung ratio AA to LA. B) 
Female lung ratio AA to LA. * different from regular diet control (Mann-Whitney U). ^ 










       
 
 
Figure 14. Ratio of DHA to ALA in male and female lung. A) Male lung ratio DHA to 
ALA. B) Female lung ratio DHA to ALA. * different from regular diet control (Mann-





            
 
 
Figure 15. Ratio of AA to DHA in male and female lung. A) Male lung ratio AA to 
DHA. B) Female lung ratio AA to DHA. * different from regular diet control (Mann-










            
 
 
Figure 16. Δ5 desaturase mRNA in male and female lung. A) Male lung Δ5 desaturase 
mRNA. B) Female lung Δ5 desaturase mRNA. * different from regular diet control 




            
 
 
Figure 17. Δ5 desaturase protein in male and female lung. A) Male lung Δ5 desaturase 
protein. B) Female lung Δ5 desaturase protein. * different from regular diet control 












             
 
 
Figure 18. Δ6 desaturase mRNA in male and female lung. A) Male lung Δ6 desaturase 
mRNA. B) Female lung Δ6 desaturase mRNA* different from regular diet control 




              
 
 
Figure 19. Δ6 desaturase protein in male and female lung. A) Male lung Δ6 desaturase 
protein. B) Female lung Δ6 desaturase protein. * different from regular diet control 











           
 
 
Figure 20. Elongase 2 mRNA in male and female lung. A) Male lung elongase 2 mRNA. 
B) Female lung elongase 2 mRNA. * different from regular diet control (Mann-Whitney 




            
 
 
Figure 21. Elongase 5 mRNA in male and female lung. A) Male lung elongase 5 mRNA. 
B) Female lung elongase 5 mRNA. * different from regular diet control (Mann-Whitney 















We hypothesized that IUGR would alter EFA and Δ5-desaturase, Δ6-desaturase, 
elongase 2 and elongase 5 levels in a sex-specific manner, and that alterations in EFA and 
Δ5-desaturase, Δ6-desaturase, elongase 2 and elongase 5 levels would be ameliorated 
with maternal DHA supplementation. This study shows, for the first time, that EFA ratios 
and EFA conversion enzymes are altered in IUGR. In addition, this study shows that 
IUGR impacts EFA ratios and EFA conversion enzymes in a sex-specific manner. It has 
been shown that IUGR affects males more severely than females [7], and the results of 
this study elucidate a potential mechanism behind the sex-specific impact of IUGR.  
Our results showed that IUGR induced sex-specific changes in circulating EFAs. 
Sex-specific differences in circulating EFAs have previously been shown in premature 
human infants. Male preterm infants have a decreased DHA to ALA ratio, and an 
increased AA to LA and total omega-6 to omega-3 ratio [9]. In our study, IUGR induced 
changes in male circulating EFAs that correlate with the altered EFA ratios seen in male 
preterm infants. 
Interestingly, DHA supplementation ameliorated the altered circulating EFAs in 
male IUGR rats.  Several studies have looked at the effect of maternal fat intake on 
circulating fetal fatty acid levels. In rats, a maternal high-fat diet rich in DHA from 
salmon oil increases downstream omega-3 EFAs in the newborn plasma [13]. A similar 
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study showed that maternal DHA supplementation from fish oil resulted in increased 
downstream omega-3 EFAs, and decreased downstream omega-6 EFAs in fetal plasma 
[14]. These results are consistent with the effect of maternal DHA supplementation on 
circulating EFAs seen in our study.  
In male circulation, but not female circulation, IUGR induced changes in the 
omega-3 pathway that were independent of diet. IUGR in males resulted in a reduction in 
the circulating ratio of DHA to ALA in both standard diet and 1% DHA diet. Despite 
exposure to the same intrauterine environment, IUGR has a sex-specific impact on the 
circulating ratio of DHA to ALA. 
We speculate two mechanisms may be responsible for the altered circulating 
omega-3 profiles seen in male IUGR rats. First, sex hormones may play a role in 
regulating omega-3 fatty acid levels in IUGR offspring. Estradiol and progesterone have 
been positively associated with circulating and tissue levels of omega-3 fatty acids, while 
testosterone has been negatively associated with circulating and tissue levels of omega-3 
fatty acids [15]. Our lab has shown that testosterone is increased and estrogen is 
decreased in male IUGR rats (unpublished). Second, circulating omega-3 EFA profiles in 
IUGR offspring may be a result of altered placental transfer of omega-3 EFAs. The 
changes seen in circulating omega-3 EFAs in male IUGR rats may be a result of IUGR 
altering the transport of longer and more desaturated EFAs in male placentas but not 
female placentas. At this time, no studies have looked at how IUGR impacts EFA transfer 
at the placental level.  
The potential role of altered placental EFA transfer on circulating EFA levels in 
IUGR infants is supported by our liver EFA conversion enzyme results. IUGR induced 
27	  
	  
changes in liver EFA conversion enzymes, and these changes did not fully explain 
alterations in circulating EFAs. Liver EFA conversion enzyme mRNA and protein was 
correlated with circulating levels of the omega-3 EFAs, but not with circulating levels of 
omega-6 EFAs. Additionally, the changes seen in circulating EFAs with DHA 
supplementation were not explained by altered liver EFA conversion enzymes. At this 
time, no other studies have correlated liver EFA conversion enzyme levels with 
circulating EFAs in IUGR offspring.  
From our results, we speculate that IUGR induced changes in circulating EFA 
levels may be a result of altered placental EFA transfer. The developing fetus must rely 
on placental transfer to receive EFAs [16]. In healthy pregnancies, there is preferential 
transfer of AA and DHA from the mother to the developing fetus [17]. A study of human 
IUGR infants found that IUGR decreases maternal-fetal transfer of DHA and AA [4]. 
The mechanisms for preferential transfer of EFAs across the placenta are not fully 
understood [18]. The placenta uptakes fatty acids from circulation by placental lipases, 
including lipoprotein lipase (LPL) and endothelial lipase [18], and by triglyceride 
hydrolase [17]. Additionally, fatty acid binding proteins play an important role in 
placental fatty acid uptake [17]. The placenta lacks the ability to modify EFAs because 
the placenta does not express Δ5 and Δ6 desaturase enzymes [19]. It was previously 
shown that the placenta in pregnancies complicated by IUGR have decreased placental 
LPL activity and decreased lipid deposition [17].  
In conjunction with selective placental uptake and transfer of EFAs, selective 
uptake of EFAs may occur in fetal tissues. Our results showed that differences in fetal 
EFA levels between circulation and the lung are not explained by alterations in lung EFA 
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conversion enzyme mRNA or protein. The ability of the lung to alter levels of EFAs from 
the circulation may be a result of selective uptake of EFAs by the lung. Tissues contain 
varying amounts of fatty acids, and tissue levels of fatty acids are often independent of 
circulating fatty acids [13]. Previous studies have demonstrated preferential uptake of 
EFAs into tissue, particularly selective uptake of DHA into the retina and brain [20, 21]. 
This suggests that tissue-specific selective transport of fatty acids occurs. Plasma fatty 
acid transport proteins are responsible for the uptake of polyunsaturated fatty acids into 
cells [22]. While the mechanisms for selective uptake of fatty acids into cells are not fully 
understood, carbon number and degree of desaturation is thought to be a determinant for 
selective uptake of EFAs into cells [21].  
            This study is not without limitations. In this study, we utilized an animal model to 
study a human condition. Our rat model of IUGR was induced surgically, and thus does 
not mimic a human maternal condition. However, the uteroplacental insufficiency (UPI)-
induced IUGR rat model used is well characterized and does mimic the effects of UPI-
induced IUGR in human infants. Additionally, our research did not address how placental 
transfer of EFAs impact EFA levels in the IUGR fetus. The rat model we used in this 
study is not appropriate to study the effect of IUGR on the placenta. However, we have a 
rat model of IUGR induced by maternal tobacco smoke that does mimic the maternal 
effects of IUGR seen in humans that will be appropriate for placental study. Finally, in 
this study we were not able to obtain serum or lung EFA levels in newborn rat pups born 
to dams fed a diet with 0.1% DHA. The 0.1% DHA diet is a more biologically relevant 
dose than the 1% DHA diet. We are not able to infer if the changes we saw in serum or 
lung EFA ratios with the 1% DHA diet would have been seen with a 0.1% DHA diet. 
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Additionally, we are not able infer if the changes we saw in liver and lung EFA 
conversion enzymes with 0.1% DHA diet would have correlated with 0.1% DHA diet 
serum or lung EFA ratios. 
             In conclusion, IUGR induced sex-specific changes in circulating EFA ratios and 
liver EFA conversion enzyme mRNA in newborn IUGR rat pups. Overall, changes in 
EFA conversion enzyme mRNA and protein did not correlate with EFA levels in 
circulation or the lung. We speculate that IUGR induced changes in EFA levels may 
occur as a result of alterations in placental EFA transfer, and that IUGR impacts placental 
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